Literature DB >> 11597520

Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?

S A Weaver1, S G Ward.   

Abstract

Carcinoma of the gastrointestinal tract is the most common internal malignancy affecting men and women in Western countries. Chronic intestinal inflammation, especially of the colon, is also a Western disease and correlates with a significantly increased risk of developing cancer. This has suggested that the immune processes involved in both conditions might share some common pathways. Indeed, there is increasing evidence that phosphatidylinositol 3-kinases (PI 3-kinases) are involved in both the pathogenesis of colorectal carcinoma and intestinal inflammation. Here, we discuss this rapidly progressing area of research, presenting evidence for a pivotal role of PI 3-kinase(s) in intestinal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597520     DOI: 10.1016/s1471-4914(01)02107-4

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  3 in total

1.  The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy.

Authors:  J Calvin Coffey; Jiang H Wang; David Bouchier-Hayes; Tom G Cotter; H Paul Redmond
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Src kinase participates in LPS-induced activation of NADPH oxidase.

Authors:  Jennifer Check; Christy L Byrd; Jade Menio; Richard A Rippe; Ian N Hines; Michael D Wheeler
Journal:  Mol Immunol       Date:  2009-11-25       Impact factor: 4.407

3.  The role of phosphoinositide 3-kinase signaling in intestinal inflammation.

Authors:  Catherine M Cahill; Jack T Rogers; W Allan Walker
Journal:  J Signal Transduct       Date:  2012-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.